Retinov is a deeptech startup that offers a digital platform called Orusight, allowing optometrists to predict their patients’ risk of developing a blinding and incurable disease that affects 2.5 million Canadians and 200 million people worldwide, called Age-related Macular Degeneration (AMD). Additionally, Retinov provides patients with personalized dietary coaching based on a blood biomarker, enabling them to monitor and act on their retinal health over time.
